STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

iSTAR Medical

Status: Active, not recruiting

Conditions: Open Angle Glaucoma

Treatments: Device: STARflo Implant

Study type: Observational

Funder types: Industry

Identifiers

NCT02825264

ISM03

Details and patient eligibility

About

STARflo is a novel suprachoroidal Glaucoma Drainage Device (GDD), bleb-free, exhibiting anti-fibrotic properties. Release of this CE Marked implant has been limited to leading Glaucoma Centers in Europe.

Full description

This Clinical Experience Program is being initiated to expand the surgical and clinical practice knowledge about the use of STARflo for reducing intraocular pression (IOP) in patients suffering from open angle glaucoma in a real world population of patients.

This program is designed to be an international multicenter observational study.

Patient data may be collected retrospectively and/or prospectively for up to 5 years after surgery.

The aim of this program is to document the patient's benefit following implantation of the STARflo implant in a real-word patient population, to learn about surgical practices and to collect data to support future cost-effectiveness analysis.

Enrollment: 70 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients suffering from open angle glaucoma or some case of narrow angle glaucoma who have been implanted with STARflo implant from 2011
• Patients who have signed a Data Release form

Exclusion criteria

• Patients who did not sign a Data Release form

Trial design

70 participants in 1 patient group

STARflo

Description:

Patients who have been implanted with STARflo implant

Treatment:

Device: STARflo Implant